Our review of the literature included relevant studies that consistently demonstrated the prognostic value of high-sensitivity cardiac troponin (hs-cTnT) in various populations of pulmonary hypertension (PH) patients. This evidence concerns the gene TNNT2 and pulmonary arterial hypertension.